Cancer Research Donn Young EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonoda, Y.
Right arrow Articles by Pieper, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonoda, Y.
Right arrow Articles by Pieper, R. O.
[Cancer Research 61, 6674-6678, September 15, 2001]
© 2001 American Association for Cancer Research

Advances in Brief

Akt Pathway Activation Converts Anaplastic Astrocytoma to Glioblastoma Multiforme in a Human Astrocyte Model of Glioma1

Yukihiko Sonoda, Tomoko Ozawa, Ken D. Aldape, Dennis F. Deen, Mitchel S. Berger and Russell O. Pieper2

Brain Tumor Research Center, Departments of Neurological Surgery, [Y. S., T. O., D. F. D., M. S. B., R. O. P.] and Pathology [K. D. A.], University of California-San Francisco, San Francisco, California 94115

Human malignant gliomas are thought to develop as the result of stepwise accumulations of multiple genetic alterations. Recently, we showed that E6/E7-mediated inactivation of p53/pRb, ras pathway activation (initiated by expression of mutant H-Ras), and expression of human telomerase reverse transcriptase (hTERT) in combination converted normal human astrocytes into cells that formed intracranial tumors resembling human anaplastic astrocytoma (AA). In this study, we created human astrocytes that, in addition to expressing E6/E7, hTERT, and Ras, also expressed a constitutive activated form of Akt intended to mimic the Akt activation noted in grade IV glioblastoma multiforme (GBM). Although these cells grew no differently than astrocytes expressing E6, E7, and H-Ras in vitro or in the first 28 days following s.c. implantation, they ultimately formed tumors four to six times larger than those formed by the E6/E7/hTERT/Ras cells. Unlike the poorly vascularized, necrosis-free AA formed by E6/E7/hTERT/Ras cells, the tumors formed by s.c. or intracranial injection of Akt-expressing cells had large areas of necrosis surrounded by neovascularization and were consistent in appearance with grade IV human GBM. These results show that activation of the Akt pathway is sufficient to allow conversion of human AA to human GBM.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Panner, C. A. Crane, C. Weng, A. Feletti, A. T. Parsa, and R. O. Pieper
A Novel PTEN-Dependent Link to Ubiquitination Controls FLIPS Stability and TRAIL Sensitivity in Glioblastoma Multiforme
Cancer Res., October 15, 2009; 69(20): 7911 - 7916.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
G. L. Gallia, B. M. Tyler, C. L. Hann, I-M. Siu, V. L. Giranda, A. L. Vescovi, H. Brem, and G. J. Riggins
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Mol. Cancer Ther., February 1, 2009; 8(2): 386 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. L. Nakamura, E. Garcia, and R. O. Pieper
S6K1 Plays a Key Role in Glial Transformation
Cancer Res., August 15, 2008; 68(16): 6516 - 6523.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
K. Sakurai and N. Osumi
The Neurogenesis-Controlling Factor, Pax6, Inhibits Proliferation and Promotes Maturation in Murine Astrocytes
J. Neurosci., April 30, 2008; 28(18): 4604 - 4612.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q.-S. Zhu, W. Ren, B. Korchin, G. Lahat, A. Dicker, Y. Lu, G. Mills, R. E. Pollock, and D. Lev
Soft Tissue Sarcoma Cells Are Highly Sensitive to AKT Blockade: A Role for p53-Independent Up-regulation of GADD45{alpha}
Cancer Res., April 15, 2008; 68(8): 2895 - 2903.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
A. B. Hjelmeland, K. P. Lattimore, B. E. Fee, Q. Shi, S. Wickman, S. T. Keir, M. D. Hjelmeland, D. Batt, D. D. Bigner, H. S. Friedman, et al.
The combination of novel low molecular weight inhibitors of RAF (LBT613) and target of rapamycin (RAD001) decreases glioma proliferation and invasion
Mol. Cancer Ther., September 1, 2007; 6(9): 2449 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C987 - C995.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kawaguchi, Y. Yamashita, M. Kanamori, R. Endersby, K. S. Bankiewicz, S. J. Baker, G. Bergers, and R. O. Pieper
The PTEN/Akt Pathway Dictates the Direct {alpha}V{beta}3-Dependent Growth-Inhibitory Action of an Active Fragment of Tumstatin in Glioma Cells In vitro and In vivo
Cancer Res., December 1, 2006; 66(23): 11331 - 11340.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Kanamori, T. Kawaguchi, M. S. Berger, and R. O. Pieper
Intracranial Microenvironment Reveals Independent Opposing Functions of Host {alpha}Vbeta3 Expression on Glioma Growth and Angiogenesis
J. Biol. Chem., December 1, 2006; 281(48): 37256 - 37264.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. J. Riemenschneider, R. A. Betensky, S. M. Pasedag, and D. N. Louis
AKT Activation in Human Glioblastomas Enhances Proliferation via TSC2 and S6 Kinase Signaling
Cancer Res., June 1, 2006; 66(11): 5618 - 5623.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. Koul, R. Shen, S. Bergh, X. Sheng, S. Shishodia, T. A. Lafortune, Y. Lu, J. F. de Groot, G. B. Mills, and W.K. A. Yung
Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma.
Mol. Cancer Ther., March 1, 2006; 5(3): 637 - 644.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
I. K. Mellinghoff, M. Y. Wang, I. Vivanco, D. A. Haas-Kogan, S. Zhu, E. Q. Dia, K. V. Lu, K. Yoshimoto, J. H.Y. Huang, D. J. Chute, et al.
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors.
N. Engl. J. Med., November 10, 2005; 353(19): 2012 - 2024.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
L. Yuan, K. Choi, C. Khosla, X. Zheng, R. Higashikubo, M. R. Chicoine, and K. M. Rich
Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas
Mol. Cancer Ther., September 1, 2005; 4(9): 1293 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Hirose, M. Katayama, O. K. Mirzoeva, M. S. Berger, and R. O. Pieper
Akt Activation Suppresses Chk2-Mediated, Methylating Agent-Induced G2 Arrest and Protects from Temozolomide-Induced Mitotic Catastrophe and Cellular Senescence
Cancer Res., June 1, 2005; 65(11): 4861 - 4869.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. M. Arsham, D. R. Plas, C. B. Thompson, and M. C. Simon
Akt and Hypoxia-Inducible Factor-1 Independently Enhance Tumor Growth and Angiogenesis
Cancer Res., May 15, 2004; 64(10): 3500 - 3507.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Kanamori, S. R. V. Berg, G. Bergers, M. S. Berger, and R. O. Pieper
Integrin {beta}3 Overexpression Suppresses Tumor Growth in a Human Model of Gliomagenesis: Implications for the Role of {beta}3 Overexpression in Glioblastoma Multiforme
Cancer Res., April 15, 2004; 64(8): 2751 - 2758.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. B. Knobbe, J. Reifenberger, B. Blaschke, and G. Reifenberger
Hypermethylation and Transcriptional Downregulation of the Carboxyl-Terminal Modulator Protein Gene in Glioblastomas
J Natl Cancer Inst, March 17, 2004; 96(6): 483 - 486.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Xie, D. Yin, X. Tong, J. O'Kelly, A. Mori, C. Miller, K. Black, D. Gui, J. W. Said, and H. P. Koeffler
Cyr61 Is Overexpressed in Gliomas and Involved in Integrin-Linked Kinase-Mediated Akt and {beta}-Catenin-TCF/Lef Signaling Pathways
Cancer Res., March 15, 2004; 64(6): 1987 - 1996.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. S. Kapoor, Y. Zhan, G. R. Johnson, and D. M. O'Rourke
Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-{kappa}B Activation through Gab1 in Glioblastoma Cells
Mol. Cell. Biol., January 15, 2004; 24(2): 823 - 836.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Sonoda, M. Kanamori, D. F. Deen, S.-Y. Cheng, M. S. Berger, and R. O. Pieper
Overexpression of Vascular Endothelial Growth Factor Isoforms Drives Oxygenation and Growth but not Progression to Glioblastoma Multiforme in a Human Model of Gliomagenesis
Cancer Res., April 15, 2003; 63(8): 1962 - 1968.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Barbero, R. Bonavia, A. Bajetto, C. Porcile, P. Pirani, J. L. Ravetti, G. L. Zona, R. Spaziante, T. Florio, and G. Schettini
Stromal Cell-derived Factor 1{alpha} Stimulates Human Glioblastoma Cell Growth through the Activation of Both Extracellular Signal-regulated Kinases 1/2 and Akt
Cancer Res., April 15, 2003; 63(8): 1969 - 1974.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Dhawan, A. B. Singh, D. L. Ellis, and A. Richmond
Constitutive Activation of Akt/Protein Kinase B in Melanoma Leads to Up-Regulation of Nuclear Factor-{kappa}B and Tumor Progression
Cancer Res., December 15, 2002; 62(24): 7335 - 7342.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Narita, M. Nagane, K. Mishima, H-J. S. Huang, F. B. Furnari, and W. K. Cavenee
Mutant Epidermal Growth Factor Receptor Signaling Down-Regulates p27 through Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway in Glioblastomas
Cancer Res., November 15, 2002; 62(22): 6764 - 6769.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
F. F. Lang, M. R. Gilbert, V. K. Puduvalli, J. Weinberg, V. A. Levin, W.K. A. Yung, R. Sawaya, G. N. Fuller, and C. A. Conrad
Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
Neuro-oncol, October 1, 2002; 4(4): 268 - 277.
[Abstract] [PDF]

Home page
 Neuro Oncol DukeHome page
C. B. Knobbe, A. Merlo, and G. Reifenberger
Pten signaling in gliomas
Neuro-oncol, July 1, 2002; 4(3): 196 - 211.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.